Effect on survival of skeletal muscle mass changes in patients with locally advanced pancreatic cancer receiving FOLFIRINOX

被引：0
|
作者：
Kim, Minseok Albert [1 ]
Lee, Jongchan [2 ]
Lee, Jong-Chan [2 ]
Cho, In Kuk [2 ]
Kim, Jaihwan [2 ]
Hwang, Jin-Hyeok [2 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Dept Internal Med GI Hepatol, Seongnam, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
locally advanced pancreatic cancer; body compositions; skeletal muscle; FOLFIRINOX;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
EE-0120 (P
引用
收藏
页码：534 / 534
页数：1
相关论文
共 50 条
  • [1] EFFECT ON SURVIVAL OF SKELETAL MUSCLE MASS CHANGES IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC CANCER RECEIVING FOLFIRINOX
    Kim, Minseok A.
    Lee, Jongchan
    Lee, Jong-chan
    Cho, In Kuk
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    GASTROENTEROLOGY, 2018, 154 (06) : S940 - S940
  • [2] THE IMPACT OF SKELETAL MUSCLE MASS LOSS IN PATIENTS WITH ADVANCED PANCREATIC CANCER DURING FOLFIRINOX
    Uemura, Shinya
    Iwashita, Takuji
    Ichikawa, Hironao
    Iwasa, Yuhei
    Mita, Naoki
    Shimizu, Masahito
    GASTROENTEROLOGY, 2020, 158 (06) : S863 - S863
  • [3] The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIRINOX therapy
    Uemura, Shinya
    Iwashita, Takuji
    Ichikawa, Hironao
    Iwasa, Yuhei
    Mita, Naoki
    Shiraki, Makoto
    Shimizu, Masahito
    BRITISH JOURNAL OF NUTRITION, 2021, 125 (10) : 1140 - 1147
  • [4] Characterization of a loss of skeletal muscle mass in advanced pancreatic cancer patients receiving chemotherapy
    Tatematsu, Noriatsu
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Association of Longitudinal Changes in Skeletal Muscle Mass With Survival in Patients With Pancreatic Cancer
    Lee, B.
    Namkoong, H.
    Yang, Y.
    Huang, H.
    Heller, D.
    Szot, G.
    Davis, M.
    Pandol, S. J.
    Bellin, M. D.
    Husain, S.
    Habtezion, A.
    PANCREAS, 2021, 50 (07) : 1073 - 1073
  • [6] PROGNOSTIC FACTORS FOR PATIENTS WITH BORDERLINE RESECTABLE OR LOCALLY ADVANCED PANCREATIC CANCER RECEIVING NEOADJUVANT FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2019, 156 (06) : S321 - S322
  • [7] Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Shin, Bang Sup
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Kwon, Wooil
    Jang, Jin-Young
    Kim, Sun-Whe
    GUT AND LIVER, 2021, 15 (02) : 315 - 323
  • [8] Locally advanced Pancreatic Cancer after FOLFIRINOX: Resection enhances Survival
    Schneider, Martin A.
    Buechler, M. W.
    CHIRURG, 2022, 93 (01): : 93 - 94
  • [9] Impact of conversion surgery on survival in locally advanced pancreatic cancer patients treated with FOLFIRINOX chemotherapy
    Lee, Mirang
    Kang, Jae Seung
    Kim, Hongbeom
    Kwon, Wooil
    Lee, Sang Hyub
    Ryu, Ji Kon
    Kim, Yong-Tae
    Oh, Do-Youn
    Chie, Eui Kyu
    Jang, Jin-Young
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (01) : 111 - 121
  • [10] FOLFIRINOX in locally advanced or metastatic pancreatic cancer
    Faris, Jason Edward
    Hong, Theodore S.
    McDermott, Shaunagh
    Guimaraes, Alexander R.
    Sahani, Dushyant
    Clark, Jeffrey W.
    Ryan, David P.
    Blaszkowsky, Lawrence Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345